U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07722000) titled 'Different Treatment Options Used for Post Covid-19 Syndrome' on July 19.

Brief Summary: This study aimed to assess functioning during the recovery phase post-COVID-19 and to evaluate symptoms prolonging after COVID-19 infection and how to manage these symptoms.

Study Start Date: Feb. 01, 2021

Study Type: INTERVENTIONAL

Condition: COVID-19 Post COVID-19 Syndrome Ginkgo Biloba Piracetam

Intervention: DRUG: Ginkgo biloba

Patients who received Ginkgo biloba alone.

DRUG: Piracetam

Patients who received piracetam alone.

DRUG: Ginkgo biloba and Piracetam

Patients who received a combination (Ginkgo biloba and Piracetam).

Recruit...